A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe.

Trial Profile

A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 07 Nov 2014

At a glance

  • Drugs Lamivudine/abacavir (Primary) ; Lamivudine/zidovudine/abacavir (Primary) ; Lopinavir/ritonavir (Primary)
  • Indications Kaposi's sarcoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Oct 2014 Status changed from active, no longer recruiting to completed, as per ClinicalTrials.gov record.
    • 07 Feb 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top